Informação geral

ECDC - Threat Assessment Brief: Implications for the EU/EEA on the spread of the SARS-CoV-2 Delta (B.1.617.2) variant of concern

European Centre for Disease Prevention and ControlBased on the available evidence, the SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) is 40-60% more transmissible than the Alpha (Β.1.1.7) VOC and may be associated with higher risk of...

ECDC - Indicator framework to evaluate the public health effectiveness of digital proximity tracing solutions

European Centre for Disease Prevention and Control

As they respond to the COVID-19 pandemic, countries worldwide have increasingly looked to digital technologies in support of public health measures for contact tracing.

CDC - Interim Guidance for Antigen Testing for SARS-CoV-2

Centers for Disease Control and PreventionThis interim guidance is intended for healthcare providers who order antigen tests, receive antigen test results, or perform point-of-care testing, as well as for laboratory professionals who...

BMJ - How long does covid-19 immunity last?

British Medical JournalHow long does covid-19 immunity last? This is difficult to say definitively. When the body’s immune system responds to an infection, it isn’t always clear how long any immunity that develops will persist. Covid-19 is a very...

AMP - Genomic Insights into the Human Susceptibility to SARS-CoV-2 Infection

Acta Médica PortuguesaOne year after the first reported case of COVID-19 in Portugal, on the 2nd of March 2020, we are acquiring knowledge at an unprecedented pace on this new infectious disease caused by the newly emerged SARS-CoV-2 virus. We...

ECDC - Risk of SARS-CoV-2 transmission from newly-infected individuals with documented previous infection or vaccination

European Centre for Disease Prevention and ControlMore than one year into the SARS-CoV-2 pandemic, over 120 million people have been infected with the virus across more than 200 countries. Reinfections following natural infections with the same...

ECDC - Introducing a coherent European framework for tuning COVID-19 response measures

European Centre for Disease Prevention and ControlThis document describes the development of a coherent, yet non-prescriptive framework for tuning COVID-19 response measures in the European Union and European Economic Area (EU/EEA). Its aim is to...

ECDC - Considerations on the use of self-tests for COVID-19 in the EU/EEA

European Centre for Disease Prevention and ControlRapid antigen detection tests (RADTs) that can be used as self-tests to detect SARS-CoV-2 are becoming available in the European Union/European Economic Area (EU/EEA). These tests require...

ECDC - Guidance for COVID-19 quarantine and testing of travellers

European Centre for Disease Prevention and ControlTravel measures, such as quarantine and testing of travellers, are designed to reduce the likelihood of SARS-CoV2 transmission prior to, during, and after travel. This document summarises the...

CDC - Operating schools during COVID-19: CDC's Considerations

Centre for Disease Prevention and ControlAs communities in the United States consider how to safely re-open K-12 school buildings for in-person learning and activities and keep them open, CDC offers updated considerations for mitigation...

ECDC - Detection and characterisation capability and capacity for SARS-CoV-2 variants within the EU/EEA

European Centre for Disease Prevention and ControlECDC’s rapid risk assessment on the spread of new SARS-CoV-2 variants of concern in the EU/EEA, published on 21 January 2021, concludes that the risk associated with the introduction and community...

AMP - SARS-CoV-2 and Cancer: Beyond Immunosuppression

Acta Médica PortuguesaOver the last year the COVID-19 pandemic has led to more than 83 million cases and 1.8 million deaths worldwide. Several conditions, such as cancer, have been identified as potential risk factors for poor outcomes of...

WHO - Contact tracing in the context of COVID-19

World Health OrganizationContact tracing is a key strategy for interrupting chains of transmission of SARS-CoV-2 and reducing COVID-19-associated mortality. This document provides updated guidance on how to establish contact tracing capacity for...

ECDC - Risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first update

European Centre for Disease Prevention and ControlViruses constantly change through mutation and variations in the SARS-CoV-2 virus, due to evolution and adaptation processes, have been observed worldwide. While most emerging mutations will not...

INFARMED - COVID-19 – Operacionalização da utilização dos Testes Rápidos de Antigénio (TRAg)

Autoridade Nacional do Medicamento e Produtos de SaúdeNo contexto da atual situação epidemiológica provocada pelo novo coronavírus SARS-CoV-2 e pela doença COVID-19, o Ministério da Saúde tem vindo a adotar e implementar medidas com vista à...